Re:This is... (Score 1)

I beg to differ on many of the things I have just read on this topic. the 2 names from temple mentioned, prior to discrediting the subject matter one would be best understanding the subject and those informing others of it. So we have a physics professor R Tao, are you aware he was selected and funded by the Rand corp to investigate an aspect of this technology (Oil related). Google Rand corp to understand how significant they are. It takes just seconds for people to voice an opinion they believe to be right, how long do you think it would take Rand to review this topic and commit funding. My point this topic is worthy of further evaluation and investigation! Tao is the Chair of the Physics department at Temple jump on their website and read up on his history, he is not in the business of snake oil. and the other name Larry F. Lemanski New hire to boost research funding Posted on 29 January 2008 Temple's research enterprise is quickly growing as newly hired Senior Vice President for Research Larry F. Lemanski has a clear vision for the future. As of Dec. 1, Lemanski began his journey to push Temple toward becoming a leading, world-renowned research institute. To achieve his goal, he said he plans to make research more "user-friendly" so it is easier for students and faculty to participate in studies and receive increased funding from various sources. Lemanski is currently scheduling seminars to educate Temple's researchers, which are meant to increase their capabilities of being successful for competitive grant funding. He also plans to work with state, local and federal legislators to get large grants through federal initiatives. "I am hoping that we can get some federal earmarks to build pillars of excellence in some areas here on campus," he said. Lemanski said he also hopes to expand translational research, patenting the discoveries of students and faculties and then licensing the technology so it can be put to use. The university receives a portion of the money earned, which would enhance all the scholarly activities of the university. Some of the money earned is for indirect expenses, ultimately providing more opportunities for Temple students. "We may not get a Gatorade like [the University of Florida] did, but we will certainly be successful in getting some things," Lemanski said. "There may be a big hit at some point where Temple will get something very large that would significantly change, in a very short time, the complexion of the university and make it a world-renowned research university." Lemanski said he decided to join Temple because he felt his past experiences fit well with what the university is ready to accomplish. He said he finds significant momentum and excitement to move to the next level of research because of the addition of President Ann Weaver Hart and Provost Lisa Staiano-Coico, who understand the importance of establishing Temple as a major research university. "Over the next five years, I think that we can accomplish tremendous amounts," Lemanski said. "I think the university can move up to a world class status in a number of areas, and I expect to be able to see the university doubling in funding during that period of time." Previously, Lemanski worked as Florida Atlantic University's first vice president for research. In five years, he increased their funding from $30 million to more than $90 million, set up their division of research, and created a Center of Excellence grant, which has yielded more than $40 million. The center also established four new companies, received 27 patents and published several works. Lemanski also has a background in teaching and said he hopes to continue that as a professor of anatomy and cell biology for the Temple's School of Medicine within the next two years. Temple University President Ann Weaver Hart has announced that Larry F. Lemanski, Ph.D., the vice president for research at Florida Atlantic University (FAU) in Boca Raton, Fla., has been named Temple's senior vice president for research and strategic initiatives. Starting on Dec. 1, 2007, Lemanski will oversee all aspects of Temple's research enterprise, including administration of sponsored research; technology transfer and commercialization of the university's intellectual property; research infrastructure, including laboratories and other facilities; partnerships with business and other organizations; and compliance with federal, state and university research regulations at all 17 of Temple's schools and colleges as well as more than a dozen interdisciplinary research centers and institutes. Lemanski will report directly to President Hart as an officer and member of her cabinet. "Building Temple's research enterprise -- with its cascading benefits to the university, the city, the state and, through the advancement of knowledge, to all humankind -- is one of the university's top priorities," President Hart said. "With his broad range of experiences at some of the nation's largest research institutions, Larry is the perfect leader to push research and research-related activity at Temple to new heights." Lemanski became FAU's first vice president for research in 2001. Since then, FAU's classification by the Carnegie Foundation for the Advancement of Teaching has been elevated to "Research University-High Research Activity." Among many other accomplishments achieved under Lemanski's leadership, FAU established a division of research, including a new office of technology transfer, and significantly expanded the Florida Atlantic University Research Corporation; almost tripled its level of research funding; and entered into collaborative agreements with various scientific and research organizations, including the Scripps Research Institute, Torrey Pines Institute for Molecular Studies, Harbor Branch Oceanographic Institution and the U.S. Geological Survey. Lemanski is currently working on a collaborative agreement between FAU and the Germany-based Max Planck Society that would include provisions for joint faculty and student recruitment opportunities, courtesy faculty appointments and a formal framework for collaborative research. During Lemanski's tenure, FAU also established two centers of excellence, one in biomedical and marine biotechnology that to date has secured $42 million in state, federal and private funding, and another in ocean energy technology that has been awarded $5 million in state funding. Prior to joining FAU, Lemanski served as the associate vice president for research, professor of medical physiology and professor of biology at Texas A&M University from 1997 to 2001. From 1983 to 1997, he was chairman and professor of anatomy and cell biology at the State University of New York Upstate Medical University, where he founded and served as the first director for an interdisciplinary cell and molecular biology program. Lemanski has also held faculty appointments at Syracuse University (1987-1997); the University of Wisconsin, Madison (1977-1983); and the University of California, San Francisco (1975-1977). "While I couldn't be more proud of the research advancements made during my tenure at Florida Atlantic University, I am thrilled at the new challenge of joining Temple at a time when the university has created an extraordinary amount of momentum and energy," Lemanski said. "President Hart, Provost Staiano-Coico and the rest of Temple's new leadership team have a clear vision of research excellence and growth -- and there's no better place in the world to do that than Philadelphia." An accomplished and prolific researcher in cellular, molecular and developmental biology -- primarily the embryology of animal heart development at the cellular and molecular level -- Lemanski also will be a professor of anatomy and cell biology in Temple's School of Medicine with a secondary appointment in the Department of Biology in the College of Science and Technology. Lemanski has authored or co-authored more than 280 research publications, book chapters, proceedings and meeting abstracts. He has served as principal investigator for more than $50 million in grant funding during his career. Lemanski has been funded continuously from the National Institutes of Health for more than three decades. Based upon work funded by NIH, Lemanski recently had a patent issued, titled "Promoting Cardiac Cell Differentiation." Lemanski has served on many national and international committees, advisory boards and peer review panels, including the NIH Roadmap for Medical Research. He has been invited to lecture around the globe and has won numerous awards. Lemanski holds a bachelor's degree in biology from the University of Wisconsin-Platteville. After earning a master's degree and a doctorate in zoology at Arizona State University, Lemanski was an NIH and Muscular Dystrophy Association postdoctoral fellow at the University of Pennsylvania. Now I dont think these people would risk reputations, other names of people who have substancial reputations and a part of this. Edward Masery CEO of STWA before he died, Erin Brochovich (not currently associated but has been in a big way in the past, and she is in a political commercial with the Chairman of STWA for Tony Strictland in the US, politicians would not hold such close friends publicly if they were not sure they are credible. Maybe read into some f STWA's board members, google these names with SEMA at the end Steve Bolio, Nate Shelton, Chuck Blum. Chuck Blum was CEO for 22 years of SEMA($30 Billion auto after market association) before leaving due to Family. Now CEO of STWA. read into this topic a little more, you dont need to change your opinion just continue to educate it over time.